White Papers

CDMO Service

Isolation, expansion, transduction, and production of endothelial-cord derived working cell bank and blood stem cell transplantation final product in support of phase I-III clinical trials in malignancy

cGMP Cell Manufacturing

A new cell therapy manufacturing methodology needed to be tech transferred to Excellos manufacturing teams in a relatively short timeline as part of initiation of Phase I and Phase II clinical trials with the product.
manufacturing process, TIL therapies applications

Non-Proliferation assay

Confirming Feeder Cells for TIL Expansion Are Suitable for Phase II Clinical Trials and Beyond